Vascular endothelial growth factor (VEGF)-induced endothelial cell migration is a key step in the angiogenic response and is mediated, in part, by an accelerated rate of focal adhesion complex assembly and disassembly. We investigated the signaling pathway by which VEGF regulates focal adhesion complex assembly by examining the signaling proteins involved. VEGF stimulated the tyrosine phosphorylation of the SH2 domain-containing signaling proteins NCK and CRK in human umbilical vein endothelial cells. The signaling pathways that couple the kinase insert domain-containing receptor to NCK and CRK is most likely mediated by another cellular protein, as NCK and CRK were tyrosine-phosphorylated in response to VEGF in cells expressing receptors mutated at each of several candidate SH2 domain-interacting cytosolic tyrosines. In the absence of VEGF treatment, NCK (but not CRK) associated with the p21 GTPase-activated kinase PAK. PAK catalytic activity was augmented after VEGF treatment; an association of PAK with 60- and 90-kDa tyrosine-phosphorylated proteins accompanied this. VEGF stimulated the recruitment of PAK to focal adhesions, and FAK immunoprecipitated with both NCK and PAK in VEGF-treated (but not untreated) human umbilical vein endothelial cells. Inhibition of NCK protein expression using antisense oligonucleotides led to the inhibition of both VEGF-induced focal adhesion assembly and VEGF-induced cell migration, demonstrating a necessary role of NCK in these cellular responses. Vascular endothelial growth factor (VEGF)-induced endothelial cell migration is a key step in the angiogenic response and is mediated, in part, by an accelerated rate of focal adhesion complex assembly and disassembly. We investigated the signaling pathway by which VEGF regulates focal adhesion complex assembly by examining the signaling proteins involved. VEGF stimulated the tyrosine phosphorylation of the SH2 domain-containing signaling proteins NCK and CRK in human umbilical vein endothelial cells. The signaling pathways that couple the kinase insert domain-containing receptor to NCK and CRK is most likely mediated by another cellular protein, as NCK and CRK were tyrosine-phosphorylated in response to VEGF in cells expressing receptors mutated at each of several candidate SH2 domain-interacting cytosolic tyrosines. In the absence of VEGF treatment, NCK (but not CRK) associated with the p21 GTPase-activated kinase PAK. PAK catalytic activity was augmented after VEGF treatment; an association of PAK with 60- and 90-kDa tyrosine-phosphorylated proteins accompanied this. VEGF stimulated the recruitment of PAK to focal adhesions, and FAK immunoprecipitated with both NCK and PAK in VEGF-treated (but not untreated) human umbilical vein endothelial cells. Inhibition of NCK protein expression using antisense oligonucleotides led to the inhibition of both VEGF-induced focal adhesion assembly and VEGF-induced cell migration, demonstrating a necessary role of NCK in these cellular responses. vascular endothelial growth factor kinase insert domain-containing receptor human umbilical vein endothelial mitogen-activated protein kinase focal adhesion kinase p120 GTPase-activating protein p21-activated kinase Dulbecco's modified Eagle's medium downstream of tyrosine kinases placenta-derived growth factor Angiogenesis, the formation of new blood capillaries, is an important component of normal physiological processes such as wound healing and development (reviewed in Ref. 1Folkman J. Shing Y. J. Biol. Chem. 1992; 267: 10931-10934Abstract Full Text PDF PubMed Google Scholar). Angiogenesis also contributes to several pathological situations, including tumor growth (2Folkman J. J. Natl. Cancer Inst. 1991; 82: 4-6Crossref Scopus (4409) Google Scholar, 3Yoshiji H. Gomez D.E. Shibuya M. Thorgeirsson U.P. Cancer Res. 1996; 56: 2013-2016PubMed Google Scholar), rheumatoid arthritis (4Fava R.A. Olsen N.J. Spencer-Green G. Yeo T.-K. Yeo K.-T. Berse B. Jackman R.W. Senger D.R. Dvorak H.F. Brown L.F. J. Exp. Med. 1994; 180: 340-346Crossref Scopus (493) Google Scholar), and degenerative eye disorders (5Pe'er J. Shweiki D. Itin A. Hemo I. Gnessin H. Keshet E. Lab. Invest. 1995; 72: 638-645PubMed Google Scholar, 6Pierce E.A. Avery R.L. Foley E.D. Aiello L.P. Smith L.E.H. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 905-909Crossref PubMed Scopus (949) Google Scholar). Angiogenesis is a complex process involving endothelial cell movement and proliferation and endothelial cell-mediated degradation of the extracellular matrix. Multiple angiogenic stimulators and inhibitors regulate these processes (7O'Reilly M.S. Boehm T. Shing Y. Kukai N. Vasios G. Lane W.S. Flynn W. Folkman J. Cell. 1997; 88: 277-285Abstract Full Text Full Text PDF PubMed Scopus (4253) Google Scholar, 8Browder T. Folkman J. Pirie-Shepard S. J. Biol. Chem. 2000; 275: 1521-1524Abstract Full Text Full Text PDF PubMed Scopus (292) Google Scholar, 9Davis S. Aldrich T.H. Jones P.F. Acheson A. Compton D.L. Jain V. Ryan T.E. Bruno J. Radziejewski C. Maisonpierre P.C. Yancopoulos G.D. Cell. 1996; 87: 1161-1169Abstract Full Text Full Text PDF PubMed Scopus (1688) Google Scholar). Vascular endothelial growth factor (VEGF)1 has received attention as a key regulator of endothelial cell functions (10Keck P.M. Hauser S.D. Krivi G. Sanzo K. Warren T. Feder J. Connolly D.T. Science. 1989; 246: 1309-1312Crossref PubMed Scopus (1801) Google Scholar, 11Leung D.W. Cachianes G. Kuang W.J. Goeddel D.V. Ferrara N. Science. 1989; 246: 1306-1309Crossref PubMed Scopus (4450) Google Scholar, 12Ferrara N. Davis-Smith T. Endocr. Rev. 1997; 18: 4-25Crossref PubMed Scopus (3668) Google Scholar). VEGF expression correlates both temporally and spatially with the onset of angiogenesis in several physiological situations (13Li J. Brown L.F. Hibberd M.G. Grossman J.D. Morgan J.P. Simons M. Am. J. Physiol. 1996; 270: H1803-H1811PubMed Google Scholar, 14Shweiki D. Itin A. Soffer D. Keshet E. Nature. 1992; 359: 843-845Crossref PubMed Scopus (4163) Google Scholar, 15Brown L.F. Berse B. Jackman R.W. Tognazzi K. Manseau E.J. Senger D.R. Dvorak H.F. Am. J. Pathol. 1993; 143: 1255-1262PubMed Google Scholar), and VEGF elicits a strong angiogenic response in a variety of in vivomodels (16Takeshita S. Zheng L. Brogi E. Kearney M. Pu L.-Q. Bunting S. Ferrara N. Symes J.F. Isner J.M. J. Clin. Invest. 1994; 93: 662-670Crossref PubMed Scopus (1000) Google Scholar, 17Majesky M.W. Circulation. 1996; 94: 3061-3064Crossref Scopus (27) Google Scholar). An essential role of VEGF in tumor angiogenesis and ischemia-related retinal disorders has been demonstrated by the findings that neutralizing anti-VEGF antibodies or dominant-negative VEGF receptors inhibit both angiogenesis and the progression of these pathological disorders (18Kim K.F. Li B. Winer J. Armanini M. Gillett N. Philips H.S. Ferrara N. Nature. 1993; 36: 841-844Crossref Scopus (3353) Google Scholar, 19Millauer B. Shawver L.K. Plate K.H. Risau W. Ullrich A. Nature. 1994; 367: 576-579Crossref PubMed Scopus (1163) Google Scholar, 20Aiello L.P. Pierce E.A. Foley E.D. Takagi H. Chen H. Riddle L. Ferrara N. King G.L. Smith L.E.H. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10457-10461Crossref PubMed Scopus (1168) Google Scholar, 21Honda M. Sakamoto T. Ishibashi T. Inomata H. Ueno H. Gene Ther. 2000; 7: 978-985Crossref PubMed Scopus (102) Google Scholar). A major component of the angiogenic response are the changes that occur in endothelial cell interactions with the extracellular matrix as well as changes in cell-cell interactions. Endothelial cells are linked to each other by tight- and adherens-type junctions and are linked to the extracellular matrix by a variety of integrin and other adhesion molecules (22Mitic L.L. Anderson J.M. Annu. Rev. Physiol. 1998; 60: 121-142Crossref PubMed Scopus (624) Google Scholar, 23Gumbiner B.M. Cell. 1996; 84: 345-357Abstract Full Text Full Text PDF PubMed Scopus (2930) Google Scholar, 24Carmeliet P. Lampugnani M.-G. Moons L. Breviario F. Compernolle V. Bono F. Balconi G. Spagnuolo R. Oostuyse G. Dewerchin M. Zanetti A. Angellilo A. Mattot V. Nuyens D. Lutgens E. Clotman F. de Ruiter M.C. Gitterberger-de Groot A. Poelmann R. Lupu F. Herbert J.-M. Collen D. Dejana E. Cell. 1999; 96: 147-157Abstract Full Text Full Text PDF Scopus (1057) Google Scholar, 25Brooks P.C. Clark R.A.F. Cheresh D.A. Science. 1994; 264: 569-572Crossref PubMed Scopus (2742) Google Scholar). VEGF activates endothelial cells, in part, through stimulating signal transduction pathways that regulate the enzymatic components of adhesion complexes. VEGF-induced tyrosine phosphorylation of VE-cadherins (26Esser S. Lampugnani M.-G. Corada M. Dejana E. Risau W. J. Cell Sci. 1998; 111: 1853-1865Crossref PubMed Google Scholar), a component of adherens-type cell-cell junctions, has been implicated as a key step in endothelial cell migration. VEGF-induced phosphorylation of the tight junction proteins occludin and zonula occluden-1 (27Kevil C.G. Payne D.K. Mire E. Alexander J.S. J. Biol. Chem. 1998; 273: 15099-15103Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 28Antonetti D.A. Barber A.J. Hollinger L.A. Wolpert E.B. Gardner T.W. J. Biol. Chem. 1999; 274: 23462-23467Abstract Full Text Full Text PDF Scopus (559) Google Scholar) is a potential mechanism by which the growth factor enhances vascular permeability. Experimental evidence indicating a role for VEGF in regulating cell-matrix interactions includes the findings that VEGF enhances the expression of α1β1 and α2β2 integrins (29Senger D.R. Claffey K.P. Benes J.E. Perruzzi C.A. Sergiou A.P. Detman M. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 13612-13617Crossref PubMed Scopus (458) Google Scholar) and that neutralizing antibodies to αvβ5 integrins block growth factor-induced neovascularization (30Friedlander M. Brooks P.C. Shaffer R.W. Kincaid C.M. Varner J.A. Cheresh D.A. Science. 1995; 270: 1500-1502Crossref PubMed Scopus (1223) Google Scholar, 31Soldi R. Mitola S. Strasly M. Defilippi P. Tarone G. Bussolino F. EMBO J. 1999; 18: 882-892Crossref PubMed Scopus (532) Google Scholar). VEGF exhibits high affinity binding to two distinct receptor tyrosine kinases, the fms-like tyrosine kinase Flt-1 (32Shibuya M. Yamguchi S. Yamane A. Ikeda T. Tojo A. Hitoshi M. Sato M. Oncogene. 1990; 14: 2079-2089Google Scholar, 33De Vries C. Escobedo J.A. Ueno H. Houck K. Ferrara N. Williams L.T. Science. 1992; 255: 989-991Crossref PubMed Scopus (1893) Google Scholar) and the kinase insert domain-containing receptor (KDR) (34Mathews W. Jordan C.T. Gavin M. Jenkins N.A. Copeland N.G. Lemischka I.R. Proc. Natl. Acad. Sci. U. S. A. 1991; 87: Scopus Google Scholar, M. D. D. P. Res. 1992; PubMed Scopus Google Scholar). receptors insert catalytic and in the extracellular and are to the growth factor of receptor tyrosine expression of both VEGF receptor in endothelial cells, including human umbilical vein endothelial cells, findings that and not is to the and of VEGF in endothelial cells B. H. L. C. J. Chen H. Ferrara N. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). The key that the functions of VEGF in endothelial cells for VEGF as to the downstream for the VEGF receptors been VEGF the tyrosine phosphorylation of and in cells and of and NCK in endothelial cells H. I. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar, D. Warren J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar). In endothelial cells with and VEGF has activity and a tyrosine phosphorylation J. L. A. Shibuya M. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). The of was to the signaling mechanism by which VEGF endothelial cell migration. is evidence that the assembly and of focal a key role in the mechanism by which several extracellular regulate both cell and movement A.P. Biol. Cell. 1996; 7: PubMed Scopus Google Scholar, Y. G. N. K. N. S. U. M. T. S. Nature. 1995; PubMed Scopus Google Scholar, D. E. Cell Biol. 2000; PubMed Scopus Google Scholar), and VEGF the tyrosine phosphorylation of FAK H. I. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar), the of the cell signaling proteins that couple VEGF binding to receptors with focal adhesion that the SH2 domain-containing signaling protein NCK and the p21 GTPase-activated kinase PAK necessary in signaling cells were as E.A. R.L. C.G. J. Clin. Invest. PubMed Scopus Google Scholar). cells were in medium human and endothelial growth factor The was in and a the cytosolic M. Oncogene. 1999; 18: PubMed Scopus Google Scholar). and antibodies were and antibodies were and were cells were The cells were in with for at or VEGF was for at or at were in and and antibodies were to the a at the antibodies were protein and the were with and in of were to and with The were in at and with antibodies for at the was with or and were through of tyrosine with was using the The oligonucleotides were for and were by The were cells, and were and as M. Oncogene. 1999; 18: PubMed Scopus Google Scholar). cells were were with VEGF for at with cells were the and in with antibodies was as The were with and with kinase and were for at with protein as a and of in of kinase The was by of of and at for The proteins were by and proteins were by of were The oligonucleotides were the NCK The of the oligonucleotides were as antisense and NCK cells were and of were for at were with medium and were to the cells, with a of a at an of medium a of oligonucleotides was were cells were or with and by antisense oligonucleotides was as and cells were in the of oligonucleotides for were in in for at and binding was with and for at or antibodies were and for at The were with by a with or antibodies with cells were a The migration a modified and was as 1998; PubMed Scopus Google Scholar). cells were to and or with or antisense oligonucleotides as the cells were the using cell for at and in medium The cells were at a of with VEGF was as a in the Cell migration were for at in a that the were with and a were for each and were in was that NCK tyrosine phosphorylation and the of NCK in are in VEGF-treated endothelial cells and endothelial cells D. Warren J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar, J. L. A. Shibuya M. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). The in and that were using cells. NCK is a of a of cell proteins that enzymatic activity and that in cell signaling by as proteins 1998; PubMed Scopus Google Scholar). that VEGF of cells the tyrosine phosphorylation of another protein, The not was in the after VEGF treatment, both are in these cells. were to the of NCK and CRK with is or mediated through another The was to receptor protein in which been mutated to in cells not and for VEGF-induced NCK and CRK tyrosine is a of the of the M. J.D. P. Res. 1994; PubMed Scopus Google Scholar, J.D. Warren J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar, A.J. J. J. 2000; PubMed Scopus Google Scholar), the that were for were to a for the NCK SH2 M. G. T. King F. T. S. Cell. 1993; 72: Full Text PDF PubMed Scopus Google Scholar, G. J. 1995; PubMed Scopus Google Scholar). cell were are and A the expression for of the cell expression were for not VEGF led to both and an of NCK and CRK in and in cells expressing as well as and A was for and not VEGF also the of NCK in for and and each of the other cell expressing a not NCK and in cells expressing and The were as for that was with or and was with or The was with the to that of the were for the and VEGF-treated to in each were in the also VEGF-induced tyrosine phosphorylation in the cell is evidence that signaling protein with at tyrosine A.J. J. J. 2000; PubMed Scopus Google Scholar). was immunoprecipitated by the VEGF-treated cell expressing and each of the cell the for and The examining VEGF-induced tyrosine phosphorylation in the cell in the and was that NCK CRK to at the by of the that were not by an or that NCK and CRK with the receptor through a protein or to at a not We PAK in VEGF-induced signal transduction by downstream demonstrated the of PAK in not not cell The at PAK and and were after with NCK VEGF the of PAK associated with NCK was by a in which cell were immunoprecipitated with the and was with the that PAK is to in the absence of growth were to the of VEGF the enzymatic activity of PAK. cells were with or and were cell PAK activity was by the phosphorylation of protein using and in the phosphorylation of protein was in VEGF-treated with cells. of other protein was in the VEGF-treated of and were with the The of the and proteins are not and is the tyrosine kinase for was that the expression of a PAK to recruitment of the protein to focal S. J. Biol. 1997; 7: Full Text Full Text PDF PubMed Scopus Google Scholar, E. Chen J.-M. T. L. Cell. Biol. 1997; PubMed Google Scholar). We is also the for PAK. In the absence of with the focal adhesions, as using or not were in these cells, were the of in the of VEGF of VEGF treatment, PAK was to the with the or demonstrating the recruitment of PAK to focal the and Flt-1 VEGF receptor are by cells. was demonstrated that VEGF-induced endothelial cell migration is mediated by and not Flt-1 B. H. L. C. J. Chen H. Ferrara N. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar), that Flt-1 not in the of VEGF PAK and focal adhesion of cells to focal adhesion The for was that which with to not The in that of cells using the was to that for cells not with growth factor VEGF stimulated focal adhesion assembly evidence indicating that VEGF the recruitment of PAK to focal is in The that FAK was in both and VEGF-treated (but not untreated) cell The in and that VEGF to NCK and PAK to focal adhesions, not the of these signaling proteins in the formation of focal or associated with these cellular complexes. these the of NCK expression using antisense oligonucleotides and the the formation of focal A the NCK was The was as a The and in of cells as using a not The using or antisense a the of the cells with cells to with with a in cell after was a in the of cells with antisense or with cells, indicating that the oligonucleotides The of cellular NCK protein was at several several that the of NCK protein was and by antisense oligonucleotides with cells to the oligonucleotides was also a in the of NCK protein after with oligonucleotides a the of CRK protein in NCK NCK cells and in of the of cells with VEGF of focal adhesion formation as by with antibodies A and is the with cells not to the cells with oligonucleotides and not with VEGF focal adhesions, and VEGF an in both and VEGF-induced of PAK to focal was also not in the cells In the absence of VEGF treatment, cells with the antisense oligonucleotides a of the focal in cells not or with in the of with the NCK antisense oligonucleotides the of focal in cells VEGF the migration of cells, and FAK has been implicated as a necessary role in response A.P. Biol. Cell. 1996; 7: PubMed Scopus Google Scholar). In of demonstrating a necessary role of NCK in focal adhesion inhibition of NCK using antisense oligonucleotides block VEGF-induced migration. The in that is in the cells with NCK antisense oligonucleotides were to VEGF or NCK cells. that VEGF signaling through NCK is for endothelial cell migration. In a signal transduction pathway that VEGF binding to receptor with focal adhesion formation and cell migration. The that VEGF binding to to the recruitment of an complex to the with tyrosine phosphorylation of PAK catalytic activity is accompanied by phosphorylation of 60- and 90-kDa The complex is to focal adhesions, which is by of cell migration. of these is in cells both the and Flt-1 VEGF receptor and NCK with both receptors after VEGF P. F. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar). that of these cells not focal adhesion is not Flt-1 signaling is to that for evidence with the that VEGF binding to the in is the that Flt-1 not in VEGF-induced cell migration B. H. L. C. J. Chen H. Ferrara N. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar) and demonstrating that VEGF of endothelial cells not to both NCK tyrosine phosphorylation and an in focal adhesion assembly J. and B. I. J. Biol. Scholar). was the in and that NCK and CRK not with after VEGF or with the receptor at a not The that were for in these were to a for the NCK SH2 M. G. T. King F. T. S. Cell. 1993; 72: Full Text PDF PubMed Scopus Google Scholar, G. J. 1995; PubMed Scopus Google Scholar). of the the growth factor receptor tyrosine kinase or Flt-1 which that is binding of the the cytosolic of are to The that most the is and other and to tyrosines. were for and in NCK or CRK were for of the cell with cells expressing the The that the binding of NCK with is is with evidence that has been for the growth factor receptor J. Li W. Oncogene. 1997; PubMed Scopus Google Scholar, P. F. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar), in which the binding of growth factor to the recruitment of the protein to the growth factor with binding of NCK to We not in cell after VEGF not receptor tyrosine kinases NCK after growth factor VEGF binding to the Flt-1 receptor to a of both NCK and CRK with Flt-1 N. C. U. L. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar). The Flt-1 is to the that are that NCK not to the An of NCK with PAK in cells and the of growth factor growth factor and growth receptors to the complex to the been W. S. R. Biol. 1997; 7: Full Text Full Text PDF PubMed Scopus Google Scholar, J. J. J. Biol. Chem. 1996; Full Text PDF PubMed Scopus Google Scholar). The association NCK and PAK is mediated by the of NCK and a in the of PAK J. J. J. Biol. Chem. 1996; Full Text PDF PubMed Scopus Google Scholar, Y. L.A. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). that PAK activity is by VEGF is with that of the NCK or of PAK to the in PAK is of other that PAK by a NCK is by of the or proteins Y. D. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar, W. Oncogene. 1999; 18: PubMed Scopus Google Scholar). The of PAK by VEGF is likely to or of PAK also been King A. S. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar). The in PAK activity is accompanied by the phosphorylation of 60- and 90-kDa of these proteins with PAK as demonstrated by using The PAK of kinases in to E. T. H. L. Nature. 1994; 367: PubMed Scopus Google Scholar, S. R.A. Cell Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), and PAK is an important mechanism by which PAK cellular is E. L. Cell. Biol. 2000; PubMed Scopus Google Scholar). The protein in A is most likely not a PAK is tyrosine-phosphorylated in response to We the that the phosphorylation of the protein is to a tyrosine kinase that with the and not PAK The of the tyrosine-phosphorylated 90-kDa PAK is also not most likely is the 90-kDa protein in by other W. S. R. Biol. 1997; 7: Full Text Full Text PDF PubMed Scopus Google Scholar, E. Chen L. I. T. L. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). is not the catalytic activity of PAK in focal adhesion or has other role in VEGF-induced the the that the in regulating of the and for PAK binding and N. N. L. P. T. J. A. Cell. 1996; 87: Full Text Full Text PDF PubMed Scopus Google Scholar, M. L. Cell. Biol. 1997; PubMed Scopus Google Scholar), that PAK activity is not for these the other an that is in or binding formation of and focal in cells S. J. Biol. 1997; 7: Full Text Full Text PDF PubMed Scopus Google Scholar, E. Chen J.-M. T. L. Cell. Biol. 1997; PubMed Google Scholar). of PAK is of kinase The the role of PAK in and changes has been by the that a of proteins and that to the and PAK and is for PAK recruitment to focal E. Chen L. I. T. L. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). that NCK in the signal transduction pathway by which VEGF endothelial cells to is with the by C. J. Cell Biol. 1999; PubMed Scopus Google Scholar). the role of PAK in endothelial cell migration after PAK by cells or by cells with or dominant-negative The of the was that PAK a role in adhesion formation and to cell the role of PAK in cell migration was to a that is to the SH2 of as a PAK as a dominant-negative of cell migration after endothelial cells. We for with the cell migration and and for with cells.
No takes yet. Share an insight, caveat, or question.
Stoletov et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: